Last update 01 Nov 2024

Biobud Ltd.

Subsidiary Company|
2000|
South Korea
|
www.biobud.com

Overview

Basic Info

Introduction
Biobud Ltd. is a biopharmaceutical company that specializes in creating drugs for the prevention, diagnosis, and treatment of cardiovascular diseases. The company was established on March 28, 2000 and is situated in Seongnam, South Korea.

Tags

Cardiovascular Diseases
Other Diseases
Biological products

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Top 5 Drug TypeCount
Biological products2

Related

3
Drugs associated with Biobud Ltd.
NC-P-002
Target-
Mechanism-
Active Org.
Biobud Ltd.
Originator Org.
Biobud Ltd.
Active Indication
Thrombosis
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
NC-P-003
Target-
Mechanism-
Active Org.
Biobud Ltd.
Originator Org.
Biobud Ltd.
Active Indication
Inflammation
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Recombinant batroxobin(Biobud Ltd.)
Target
Fibrinogen
Mechanism
Fibrinogen inhibitors
Active Org.-
Originator Org.
Biobud Ltd.
Active Indication-
Inactive Indication
Blood Coagulation Disorders
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Biobud Ltd.
KCT0004404 / RecruitingNot Applicable
A prospective, multicenter, single-blind, randomized, active-controlled, non-inferiority pivotal study to evaluate the safety and efficacy of Stopad versus Tachosil in patients with oozing after primary control of bleeding by standard techniques (such as sutures, ligatures, clips, vascular stapler, electrocautery, local radiofrequency ablation) in open hepatic resection
KCT0002518 / CompletedPhase 1
A Dose Block-Randomized, Double-Blinded, Placebo-Controlled, Single-Dosing, Dose Escalation Phase I Clinical Trial to Evaluate Tolerability, Safety and Pharmacodynamics of BB-rB1 (recombinant batroxobin) in Healthy Volunteers
100 Clinical Results associated with Biobud Ltd.
Login to view more data
0 Patents (Medical) associated with Biobud Ltd.
Login to view more data
100 Deals associated with Biobud Ltd.
Login to view more data
100 Translational Medicine associated with Biobud Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
NC-P-003
Inflammation
More
Preclinical
NC-P-002
Thrombosis
More
Preclinical
Recombinant batroxobin(Biobud Ltd.)
 ( Fibrinogen )		Blood Coagulation Disorders
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free